Logo image of SEV

SONO GROUP NV (SEV) Stock Fundamental Analysis

NASDAQ:SEV - Nasdaq - NL0015000N74 - Common Stock - Currency: USD

0.207  -0.02 (-8.33%)

After market: 0.2 -0.01 (-3.38%)

Fundamental Rating

2

Overall SEV gets a fundamental rating of 2 out of 10. We evaluated SEV against 80 industry peers in the Automobile Components industry. The financial health of SEV is average, but there are quite some concerns on its profitability. SEV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SEV has reported negative net income.
SEV Yearly Net Income VS EBIT VS OCF VS FCFSEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -20M -40M -60M

1.2 Ratios

SEV has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEV Yearly ROA, ROE, ROICSEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 200 400 600 800 1K

1.3 Margins

SEV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEV Yearly Profit, Operating, Gross MarginsSEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 -100K -200K -300K

More info and screens

4

2. Health

2.1 Basic Checks

SEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SEV has more shares outstanding
The debt/assets ratio for SEV has been reduced compared to a year ago.
SEV Yearly Shares OutstandingSEV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M
SEV Yearly Total Debt VS Total AssetsSEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 50M 100M

2.2 Solvency

SEV has an Altman-Z score of -5.13. This is a bad value and indicates that SEV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -5.13, SEV is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.24 indicates that SEV is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.24, SEV is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -5.13
ROIC/WACCN/A
WACC6.5%
SEV Yearly LT Debt VS Equity VS FCFSEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.93 indicates that SEV has no problem at all paying its short term obligations.
The Current ratio of SEV (2.93) is better than 66.67% of its industry peers.
SEV has a Quick Ratio of 2.93. This indicates that SEV is financially healthy and has no problem in meeting its short term obligations.
SEV has a Quick ratio of 2.93. This is amongst the best in the industry. SEV outperforms 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.93
SEV Yearly Current Assets VS Current LiabilitesSEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 50M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SEV have decreased strongly by -31.76% in the last year.
EPS 1Y (TTM)-31.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SEV will show a small growth in Earnings Per Share. The EPS will grow by 3.33% on average per year.
Based on estimates for the next years, SEV will show a very strong growth in Revenue. The Revenue will grow by 745.34% on average per year.
EPS Next Y4.23%
EPS Next 2Y34.27%
EPS Next 3Y8.62%
EPS Next 5Y3.33%
Revenue Next Year9900%
Revenue Next 2Y1691.95%
Revenue Next 3Y2072.21%
Revenue Next 5Y745.34%

3.3 Evolution

SEV Yearly Revenue VS EstimatesSEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
SEV Yearly EPS VS EstimatesSEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SEV. In the last year negative earnings were reported.
Also next year SEV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEV Price Earnings VS Forward Price EarningsSEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEV Per share dataSEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.27%
EPS Next 3Y8.62%

More info and screens

0

5. Dividend

5.1 Amount

SEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONO GROUP NV

NASDAQ:SEV (7/20/2023, 8:20:59 PM)

After market: 0.2 -0.01 (-3.38%)

0.207

-0.02 (-8.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)06-21 2023-06-21/amc
Earnings (Next)N/A N/A
Inst Owners39.89%
Inst Owner ChangeN/A
Ins Owners0.6%
Ins Owner Change0%
Market Cap18.19M
Analysts77.14
Price Target2.69 (1199.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-66.87%
Min EPS beat(2)-80.62%
Max EPS beat(2)-53.11%
EPS beat(4)0
Avg EPS beat(4)-49.12%
Min EPS beat(4)-80.62%
Max EPS beat(4)-13.62%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.1%
Min Revenue beat(2)-81.01%
Max Revenue beat(2)-73.19%
Revenue beat(4)0
Avg Revenue beat(4)-82.51%
Min Revenue beat(4)-91.68%
Max Revenue beat(4)-73.19%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)32.99%
EPS NQ rev (1m)-29.82%
EPS NQ rev (3m)-24.72%
EPS NY rev (1m)49.44%
EPS NY rev (3m)49.44%
Revenue NQ rev (1m)37.79%
Revenue NQ rev (3m)40.93%
Revenue NY rev (1m)167.91%
Revenue NY rev (3m)167.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 76.48
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-2.92
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 2.93
Altman-Z -5.13
F-ScoreN/A
WACC6.5%
ROIC/WACCN/A
Cap/Depr(3y)269.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y4.23%
EPS Next 2Y34.27%
EPS Next 3Y8.62%
EPS Next 5Y3.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year9900%
Revenue Next 2Y1691.95%
Revenue Next 3Y2072.21%
Revenue Next 5Y745.34%
EBIT growth 1Y-9.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.52%
EBIT Next 3Y15.2%
EBIT Next 5Y37%
FCF growth 1Y-3873.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3874.79%
OCF growth 3YN/A
OCF growth 5YN/A